GOSS

SEC source: 0001867872-25-000003 · wk-form4_1759436003.xml · nonDerivative · entry 1

Aranda Richard · CIK 0001867872 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 369,356

F1 · shares: Represents performance stock unit award, which will vest in full upon the earlier of (i) the approval of a new drug application for seralutinib or (ii) a change in control, in either case on or prior to the fourth anniversary of the grant date, and subject to the Reporting Person's continuous service to the Issuer.

SEC source: 0001857256-25-000004 · wk-form4_1759435889.xml · nonDerivative · entry 1

Peterson Caryn · CIK 0001857256 · EVP, Regulatory Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,833

F1 · shares: Represents performance stock unit award, which will vest in full upon the earlier of (i) the approval of a new drug application for seralutinib or (ii) a change in control, in either case on or prior to the fourth anniversary of the grant date, and subject to the Reporting Person's continuous service to the Issuer.

SEC source: 0001728117-25-000072 · wk-form4_1755720270.xml · nonDerivative · entry 1

Milligan Sandra · CIK 0001859810 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,050

SEC source: 0001728117-25-000059 · wk-form4_1750970345.xml · derivative · entry 1

Nathan Steven D · CIK 0002015114 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2035-06-24

F1 · shares: Award made pursuant to Non-Employee Director Compensation Program.

F2 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

SEC source: 0001728117-25-000051 · wk-form4_1750970138.xml · derivative · entry 1

Drynan Skye · CIK 0002015102 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2035-06-24

F1 · shares: Award made pursuant to Non-Employee Director Compensation Program.

F2 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

SEC source: 0001728117-25-000057 · wk-form4_1750970302.xml · derivative · entry 1

Cox Russell J. · CIK 0001512984 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2035-06-24

F1 · shares: Award made pursuant to Non-Employee Director Compensation Program.

F2 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

SEC source: 0001728117-25-000061 · wk-form4_1750970422.xml · derivative · entry 1

Daniel Thomas O · CIK 0001538894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2035-06-24

F1 · shares: Award made pursuant to Non-Employee Director Compensation Program.

F2 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

SEC source: 0001728117-25-000055 · wk-form4_1750970243.xml · derivative · entry 1

Quisel John D · CIK 0001586788 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2035-06-24

F1 · shares: Award made pursuant to Non-Employee Director Compensation Program.

F2 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

SEC source: 0001728117-25-000053 · wk-form4_1750970185.xml · derivative · entry 1

Milligan Sandra · CIK 0001859810 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2035-06-24

F1 · shares: Award made pursuant to Non-Employee Director Compensation Program.

F2 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

SEC source: 0001728117-25-000013 · wk-form4_1741295198.xml · derivative · entry 1

Smith Robert Paul JR · CIK 0002003059 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 572,000

Underlying: Common Stock · 572,000 shares

Expires 2035-03-03

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on March 4, 2026 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-25-000008 · wk-form4_1741294981.xml · derivative · entry 1

Hasnain Faheem · CIK 0001352620 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,540,000

Underlying: Common Stock · 1,540,000 shares

Expires 2035-03-03

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on March 4, 2026 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-25-000015 · wk-form4_1741295273.xml · derivative · entry 1

Christian Waage · CIK 0001553179 · EVP, Tech Ops and Admin

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 440,000

Underlying: Common Stock · 440,000 shares

Expires 2035-03-03

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on March 4, 2026 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-25-000017 · wk-form4_1741295347.xml · derivative · entry 1

Peterson Caryn · CIK 0001857256 · EVP, Regulatory Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 440,000

Underlying: Common Stock · 440,000 shares

Expires 2035-03-03

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on March 4, 2026 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-25-000012 · wk-form4_1741295144.xml · derivative · entry 1

Aranda Richard · CIK 0001867872 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 572,000

Underlying: Common Stock · 572,000 shares

Expires 2035-03-03

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on March 4, 2026 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-25-000010 · wk-form4_1741295043.xml · derivative · entry 1

Giraudo Bryan · CIK 0001740847 · COO/CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 638,000

Underlying: Common Stock · 638,000 shares

Expires 2035-03-03

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on March 4, 2026 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-24-000078 · wk-form4_1719354282.xml · nonDerivative · entry 1

Aranda Richard · CIK 0001867872 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,891

F1 · shares: Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001728117-24-000076 · wk-form4_1719265930.xml · nonDerivative · entry 1

Hasnain Faheem · CIK 0001352620 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By family trust

Disclosed balance after: 5,408,073

F1 · kind: The Reporting Person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 23,172 shares, with the Reporting Person's sale of 23,172 shares of common stock at a price of $1.1554 per share on March 27, 2024. The Reporting Person paid to the Issuer $11,349.86, representing the full amount of the profit realized in connection with the short-swing transaction.

F2 · price: This transaction was executed in multiple trades at prices ranging from $0.6079 to $0.7217 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

SEC source: 0001728117-24-000073 · wk-form4_1718929291.xml · nonDerivative · entry 1

Giraudo Bryan · CIK 0001740847 · COO/CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By family trust

Disclosed balance after: 480,010

F1 · kind: The Reporting Person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 6,430 shares, with the Reporting Person's sale of 6,430 shares of common stock at a price of $1.1556 per share on March 27, 2024. The reporting person has agreed to pay to the Issuer $3,653.10, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.

SEC source: 0001728117-24-000072 · wk-form4_1718929213.xml · nonDerivative · entry 1

Smith Robert Paul JR · CIK 0002003059 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By family trust

Disclosed balance after: 25,000

SEC source: 0001728117-24-000065 · wk-form4_1717725481.xml · derivative · entry 1

Cox Russell J. · CIK 0001512984 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2034-06-05

F1 · shares: Award made pursuant to Non-Employee Director Compensation Program.

F2 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

SEC source: 0001728117-24-000064 · wk-form4_1717725462.xml · derivative · entry 1

Daniel Thomas O · CIK 0001538894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2034-06-05

F1 · shares: Award made pursuant to Non-Employee Director Compensation Program.

F2 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

SEC source: 0001728117-24-000067 · wk-form4_1717725537.xml · derivative · entry 1

Quisel John D · CIK 0001586788 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2034-06-05

F1 · shares: Award made pursuant to Non-Employee Director Compensation Program.

F2 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

SEC source: 0001728117-24-000066 · wk-form4_1717725502.xml · derivative · entry 1

Milligan Sandra · CIK 0001859810 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2034-06-05

F1 · shares: Award made pursuant to Non-Employee Director Compensation Program.

F2 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

SEC source: 0001728117-24-000037 · wk-form4_1711663290.xml · nonDerivative · entry 1

Hasnain Faheem · CIK 0001352620 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,293

F1 · shares: Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.1603 to $1.1551 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

SEC source: 0001728117-24-000041 · wk-form4_1711664190.xml · nonDerivative · entry 1

Christian Waage · CIK 0001553179 · EVP, Tech Ops and Admin

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 585,934

F1 · shares: Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.1551 to $1.1626 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

SEC source: 0001728117-24-000039 · wk-form4_1711663523.xml · nonDerivative · entry 1

Giraudo Bryan · CIK 0001740847 · COO/CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,737

F1 · shares: Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.1551 to $1.165 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

SEC source: 0001728117-24-000034 · wk-form4_1710888644.xml · nonDerivative · entry 1

Aranda Richard · CIK 0001867872 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,799

F1 · shares: Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.329 to $1.331 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

SEC source: 0001728117-24-000033 · wk-form4_1710888581.xml · nonDerivative · entry 1

Peterson Caryn · CIK 0001857256 · EVP, Regulatory Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,833

F1 · shares: Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.329 to $1.335 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

SEC source: 0001728117-24-000031 · wk-form4_1710287576.xml · derivative · entry 1

Drynan Skye · CIK 0002015102 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,000

Underlying: Common Stock · 230,000 shares

Expires 2034-03-10

F1 · derivative.exercise_price: 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date.

F1 · derivative.exercise_date: 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date.

SEC source: 0001728117-24-000029 · wk-form4_1710287443.xml · derivative · entry 1

Nathan Steven D · CIK 0002015114 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,000

Underlying: Common Stock · 230,000 shares

Expires 2034-03-10

F1 · derivative.exercise_date: 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date.

SEC source: 0001728117-24-000002 · wk-form4_1704405629.xml · derivative · entry 1

Hasnain Faheem · CIK 0001352620 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,312,500

Underlying: Common Stock · 1,312,500 shares

Expires 2034-01-01

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on January 2, 2025 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-24-000008 · wk-form4_1704406067.xml · derivative · entry 1

Christian Waage · CIK 0001553179 · EVP, Tech Ops and Admin

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 375,000

Underlying: Common Stock · 375,000 shares

Expires 2034-01-01

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on January 2, 2025 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-24-000010 · wk-form4_1704406275.xml · derivative · entry 1

Peterson Caryn · CIK 0001857256 · EVP, Regulatory Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 375,000

Underlying: Common Stock · 375,000 shares

Expires 2034-01-01

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on January 2, 2025 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-24-000004 · wk-form4_1704405725.xml · derivative · entry 1

Giraudo Bryan · CIK 0001740847 · COO/CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 543,750

Underlying: Common Stock · 543,750 shares

Expires 2034-01-01

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on January 2, 2025 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-24-000006 · wk-form4_1704405870.xml · derivative · entry 1

Aranda Richard · CIK 0001867872 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 487,500

Underlying: Common Stock · 487,500 shares

Expires 2034-01-01

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on January 2, 2025 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-23-000164 · wk-form4_1701814328.xml · derivative · entry 1

Smith Robert Paul JR · CIK 0002003059 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500,000

Underlying: Common Stock · 1,500,000 shares

Expires 2033-12-03

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on December 4, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-23-000160 · wk-form4_1701301079.xml · derivative · entry 1

Quisel John D · CIK 0001586788 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,000

Underlying: Common Stock · 230,000 shares

Expires 2033-11-27

F1 · derivative.exercise_date: 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date.

SEC source: 0001728117-23-000145 · wk-form4_1700698023.xml · derivative · entry 1

Hasnain Faheem · CIK 0001352620 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 437,500

Underlying: Common Stock · 437,500 shares

Expires 2033-11-19

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on November 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-23-000144 · wk-form4_1700698009.xml · derivative · entry 1

Christian Waage · CIK 0001553179 · EVP, Tech Ops and Admin

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2033-11-19

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on November 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-23-000148 · wk-form4_1700698065.xml · derivative · entry 1

Aranda Richard · CIK 0001867872 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,500

Underlying: Common Stock · 162,500 shares

Expires 2033-11-19

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on November 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-23-000147 · wk-form4_1700698050.xml · derivative · entry 1

Giraudo Bryan · CIK 0001740847 · COO/CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,250

Underlying: Common Stock · 181,250 shares

Expires 2033-11-19

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on November 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-23-000146 · wk-form4_1700698037.xml · derivative · entry 1

Peterson Caryn · CIK 0001857256 · EVP, Regulatory Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2033-11-19

F1 · derivative.exercise_date: 25% of the total number of shares subject to the option will vest on November 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

SEC source: 0001728117-23-000138 · wk-form4_1700254868.xml · nonDerivative · entry 1

Milligan Sandra · CIK 0001859810 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By family trust

Disclosed balance after: 32,000

SEC source: 0001728117-23-000136 · wk-form4_1700004245.xml · nonDerivative · entry 1

Giraudo Bryan · CIK 0001740847 · COO/CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By family trust

Disclosed balance after: 380,010

F1 · price: This transaction was executed in multiple trades at prices ranging from $0.5557 to $0.5723 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

SEC source: 0001728117-23-000099 · wf-form4_169040174487113.xml · derivative · entry 3

Hasnain Faheem · CIK 0001352620 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By family trust

Disclosed balance after: 135,044

Underlying: Common Stock · 135,044 shares

Expires 2028-07-24

SEC source: 0001728117-23-000099 · wf-form4_169040174487113.xml · nonDerivative · entry 1

Hasnain Faheem · CIK 0001352620 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By family trust

Disclosed balance after: 5,036,073

SEC source: 0001728117-23-000098 · wf-form4_169040168831720.xml · derivative · entry 4

Christian Waage · CIK 0001553179 · EVP, Tech Ops and Admin

10b5-1 filing: No plan indicated

Ownership: Indirect · By family trust

Disclosed balance after: 3,376

Underlying: Common Stock · 3,376 shares

Expires 2028-07-24

SEC source: 0001728117-23-000098 · wf-form4_169040168831720.xml · nonDerivative · entry 1

Christian Waage · CIK 0001553179 · EVP, Tech Ops and Admin

10b5-1 filing: No plan indicated

Ownership: Indirect · By family trust

Disclosed balance after: 45,892

SEC source: 0001728117-23-000100 · wf-form4_169040180880782.xml · derivative · entry 3

Giraudo Bryan · CIK 0001740847 · COO/CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By family trust

Disclosed balance after: 13,505

Underlying: Common Stock Purchase Warrants · 13,505 shares

Expires 2028-07-24

SEC source: 0001728117-23-000100 · wf-form4_169040180880782.xml · nonDerivative · entry 1

Giraudo Bryan · CIK 0001740847 · COO/CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By family trust

Disclosed balance after: 180,010